Interestingly, increased O-GlcNAcylation in lung cancer promotes p53 ubiquitination and degradation (59), while reduced O-GlcNAcylation stabilizes p53 and increases the efficacy of doxorubicin in hepatocellular carcinoma (31). The gene discussed is TP53; the disease is hepatocellular carcinoma.